Sales revenue discussion, page-131

I often chuckle when analysts/investors mention their feelings in discussion but anyway, your most recent comment is well taken, I was merely mapping out a path to $80m-$100m annual sales in FY23 with the dependence on sales hiring. It is optimistic but not unreasonable, call it a best case scenario.

As an aside, and as previously briefly mentioned on these boards, BTM could make a major presence in German and Polish hospitals in the near term. Personally, I expect this Ukraine situation to carry on for some time on the basis of the current rhetoric of western governments and media which is anything but conciliatory. In the real world, you can't walk back public claims of 'war criminal' and 'butcher'.